Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian J Liddicoat

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Cell|June 20, 2020
Place Your BETs in Combination TherapyBrian J Liddicoat, Mark A Dawson
Wiley Interdisciplinary Reviews. RNA|December 23, 2015
ADAR1, inosine and the immune sensing system: distinguishing self from non-selfBrian J Liddicoat, Alistair M Chalk, Carl R Walkley
Experimental Hematology|September 22, 2020
The old and the new: DNA and RNA methylation in normal and malignant hematopoiesisAndrew A Guirguis, Brian J Liddicoat, Mark A Dawson
Science (New York, N.Y.)|August 15, 2015
RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonselfBrian J Liddicoat, Robert Piskol, Alistair M Chalk, et al.
Science (New York, N.Y.)|November 3, 2018
Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBNQuinlan L Sievers, Georg Petzold, Richard D Bunker, et al.
Genome Biology|September 7, 2017
Protein recoding by ADAR1-mediated RNA editing is not essential for normal development and homeostasisJacki E Heraud-Farlow, Alistair M Chalk, Sandra E Linder, et al.
Experimental Hematology|July 5, 2016
Adenosine-to-inosine RNA editing by ADAR1 is essential for normal murine erythropoiesisBrian J Liddicoat, Jochen C Hartner, Robert Piskol, et al.
Plos One|September 9, 2017
Extrinsically derived TNF is primarily responsible for limiting antiviral CD8+ T cell response magnitudeKylie M Quinn, Wan-Ting Kan, Katherine A Watson, et al.
Blood|May 3, 2019
Patterns of substrate affinity, competition, and degradation kinetics underlie biological activity of thalidomide analogsAdam S Sperling, Michael Burgess, Hasmik Keshishian, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Cell|June 20, 2020
Place Your BETs in Combination TherapyBrian J Liddicoat, Mark A Dawson
Wiley Interdisciplinary Reviews. RNA|December 23, 2015
ADAR1, inosine and the immune sensing system: distinguishing self from non-selfBrian J Liddicoat, Alistair M Chalk, Carl R Walkley
Experimental Hematology|September 22, 2020
The old and the new: DNA and RNA methylation in normal and malignant hematopoiesisAndrew A Guirguis, Brian J Liddicoat, Mark A Dawson
Science (New York, N.Y.)|August 15, 2015
RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonselfBrian J Liddicoat, Robert Piskol, Alistair M Chalk, et al.
Science (New York, N.Y.)|November 3, 2018
Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBNQuinlan L Sievers, Georg Petzold, Richard D Bunker, et al.
Genome Biology|September 7, 2017
Protein recoding by ADAR1-mediated RNA editing is not essential for normal development and homeostasisJacki E Heraud-Farlow, Alistair M Chalk, Sandra E Linder, et al.
Experimental Hematology|July 5, 2016
Adenosine-to-inosine RNA editing by ADAR1 is essential for normal murine erythropoiesisBrian J Liddicoat, Jochen C Hartner, Robert Piskol, et al.
Plos One|September 9, 2017
Extrinsically derived TNF is primarily responsible for limiting antiviral CD8+ T cell response magnitudeKylie M Quinn, Wan-Ting Kan, Katherine A Watson, et al.
Blood|May 3, 2019
Patterns of substrate affinity, competition, and degradation kinetics underlie biological activity of thalidomide analogsAdam S Sperling, Michael Burgess, Hasmik Keshishian, et al.
Pageof 1